We noticed you're blocking ads.

Keep supporting great journalism by turning off your ad blocker.

Questions about why you are seeing this? Contact us

Font Size

- Aa +

Sat 3 Dec 2016 12:47 AM

Font Size

- Aa +

UAE's Zulekha opens first Indian hospital in $43m deal

Zulekha Hospitals Group announces opening of Alexis Multi-Speciality Hospital in Nagpur

UAE's Zulekha opens first Indian hospital in $43m deal

UAE-based Zulekha Hospitals Group has announced its first foray overseas with the opening of a new hospital in Nagpur, India.

The $43.6 million Alexis Multi-Speciality Hospital in Nagpur was inaugurated by Shri Nitin Gadkari, India's Minister for Road Transport and Highways and Shipping, and Dr Zulekha Daud, founder and chairperson of Zulekha Healthcare Group.

Spanning an area of 225,000 sq ft, the hospital provides care across various disciplines, including centres of excellence in cardiac sciences, ENT, orthopaedics, joint replacement, neurosciences, paediatrics and neonatology, trauma services, urology, nephrology, gastroenterology, endocrinology and minimal invasive surgery.

The hospital also features oncology and radiotherapy, preventive medicines and critical care services, while its organ transplant unit is set to open soon.

Taher Shams, managing director of Zulekha Hospitals and Alexis Multispeciality Hospital, said: “We are delighted and proud to mark our international footprint by sharing our world-class expertise and contributing to the region’s healthcare system and its community.

“We are already recognised as a forerunner in the UAE’s healthcare industry, but our step towards international expansion is underlined by Zulekha Hospitals’ commitment to providing high quality healthcare to all patients and society at large.”

Implemented in collaboration with the University of California, San Francisco (UCSF), the hospital will offer 200 beds, a statement said.

Arabian Business: why we're going behind a paywall

For all the latest health tips & news from the UAE and Gulf countries, follow us on Twitter and Linkedin, like us on Facebook and subscribe to our YouTube page, which is updated daily.